InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,614.80
(
0.52%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
80.31
(
-0.34%
)
Bitcoin
69,593.99
(
2.65%
)
Post# of 42706
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Joe1984

Send PM Follow Ignore
Followers 22
Posts 2880
Boards Moderated 0
Alias Born 08/20/2009

Joe1984

Re: gatorboy post# 21149

Thursday, 02/18/2010 7:53:24 PM

Thursday, February 18, 2010 7:53:24 PM

Post# of 42706
Not trying to say they are not bringing in alot of revenues but just because some of their customers are big, Nasdaq/NYSE corporations does not necessarily mean they have huge revenues. I work at a small biotech company and some of our customers include Arqule ($3.50 Nasdaq stock), Seattle Genetics ($10.25 Nasdaq stock), Genzyme ($55 Nasdaq stock), Amgen ($57 Nasdaq stock), Yale, Harvard, and more. Yet our revenues are only about $300-350,000 per year. In case I missed it, has anyone (probably would have been Me2) ever found out the cost of some of their services?

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up